NHS ester-Val-Cit-PAB-MMAE

NHS ester-Val-Cit-PAB-MMAE

NHS ester-Val-Cit-PAB-MMAE is a precursor of antibody-drug conjugates (ADCs). It contains a cathepsin-cleavable Val-Cit dipeptide and MMAE payload. The MMAE is a synthetic antineoplastic agent. It can be attached to a monoclonal antibody which directs it toward cancer cells. The NHS ester is able to react specifically and efficiently with amines (e.g. the side chain of lysine residues or aminosilane-coated surfaces) at neutral or slightly basic condition to form a covalent bond. Please contact us for GMP-grade inquiries.

Molecular structure of the compound BP-41657
    • Unit
    • Price
    • Qty
    • 1 MG
    • $540.00
    • 5 MG
    • $1500.00
    • 10 MG
    • $2400.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire

Product Citations

  1. Doherty, C. D.; Jain, S.; Ott, L. L.; Bakken, K. K.; Wilbanks, B. A.; Burgenske, D. M.; Pearson, K. S.; Griffith, J. I.; Tian, Z.; Meridew, J. A.; Yerneni, S. S.; Elmquist, W. F.; Sarkaria, J. N.; Maher, L. J. In Vivo Selection of Anti-Glioblastoma DNA Aptamer-Drug Conjugates in an Orthotopic Patient-Derived Xenograft Model. 2026.
    https://doi.org/10.64898/2026.02.16.706148